Literature DB >> 10698241

Selective screening for chlamydial infection: which criteria to use?

W C Miller1, I F Hoffman, J Owen-O'Dowd, J T McPherson, A Privette, J L Schmitz, G Woodlief, P A Leone.   

Abstract

BACKGROUND: Screening sexually active women for Chlamydia trachomatis is necessary to detect asymptomatic infections. Selective screening is a common strategy because universal screening is too costly in many settings. In order to guide local programs in the choice of selective screening criteria, we examined the performance of previously proposed screening criteria for C. trachomatis.
METHODS: A clinic-based, cross-sectional study was conducted in public family planning and sexually transmitted disease (STD) clinics in ten counties in North Carolina. Women (n = 4471 in family planning and n = 2201 in STD clinics) undergoing pelvic examination were enrolled consecutively. Nine sets of screening criteria, including age alone, were compared using sensitivity, specificity, number of tests required and receiver-operator characteristic (ROC) analysis. All women underwent testing with ligase chain reaction assay of cervical specimens to identify C trachomatis infection.
RESULTS: The prevalence of C. trachomatis was 7.8% and 11.0% in family planning and STD clinics, respectively. The sensitivities of published criteria ranged from 0.50 to 0.97. Specificities ranged from 0.05 to 0.66. In family planning clinics, the best performing criteria would detect 84% of infections while screening 51% of women. In STD clinics, the same criteria would detect 83% of infections but require testing 67% of women. Testing women aged < or =22 would detect 77% of infections in family planning and 74% of infections in STD clinics, while testing 51% and 48% of the women, respectively.
CONCLUSIONS: When site-specific criteria cannot be developed, age alone is an acceptable strategy for selective screening for chlamydial infection.

Entities:  

Mesh:

Year:  2000        PMID: 10698241     DOI: 10.1016/s0749-3797(99)00146-4

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  5 in total

1.  A prediction rule for selective screening of Chlamydia trachomatis infection.

Authors:  H M Götz; J E A M van Bergen; I K Veldhuijzen; J Broer; C J P A Hoebe; E W Steyerberg; A J J Coenen; F de Groot; M J C Verhooren; D T van Schaik; J H Richardus
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

2.  Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection.

Authors:  Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

3.  Cervical Infection with Herpes simplex Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae among Symptomatic Women, Dubai, UAE: A Molecular Approach.

Authors:  Davood Mehrabani; Mohammad Amin Behzadi; Saeed Azizi; Hamid Payombarnia; Ali Vahdani; Mandana Namayandeh; Mazyar Ziyaeyan
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-05-27

4.  Screening for Chlamydia trachomatis infection among infertile women in Saudi Arabia.

Authors:  Remah M Kamel
Journal:  Int J Womens Health       Date:  2013-06-06

5.  Risk prediction in sexual health contexts: protocol.

Authors:  Titilola Falasinnu; Paul Gustafson; Mark Gilbert; Jean Shoveller
Journal:  JMIR Res Protoc       Date:  2013-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.